hydroxyproline has been researched along with Vitreoretinopathy, Proliferative in 1 studies
Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.
Vitreoretinopathy, Proliferative: Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy of sustained-release cis-4-hydroxyproline (CHP), a proline analog that inhibits collagen secretion, on experimental proliferative vitreoretinopathy (PVR) in rabbits." | 7.71 | Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits. ( Honda, Y; Kimura, H; Miyamoto, H; Ogura, Y; Tabata, Y; Yasukawa, T, 2002) |
| "To evaluate the efficacy of sustained-release cis-4-hydroxyproline (CHP), a proline analog that inhibits collagen secretion, on experimental proliferative vitreoretinopathy (PVR) in rabbits." | 3.71 | Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits. ( Honda, Y; Kimura, H; Miyamoto, H; Ogura, Y; Tabata, Y; Yasukawa, T, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yasukawa, T | 1 |
| Kimura, H | 1 |
| Tabata, Y | 1 |
| Miyamoto, H | 1 |
| Honda, Y | 1 |
| Ogura, Y | 1 |
1 other study available for hydroxyproline and Vitreoretinopathy, Proliferative
| Article | Year |
|---|---|
Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits.
Topics: Absorbable Implants; Animals; Biocompatible Materials; Chromatography, High Pressure Liquid; Delayed | 2002 |